Related Experiment Videos
Lung function in essential mixed cryoglobulinemia: a short-term follow-up
Clinical Rheumatology
|September 1, 1989
Summary
Essential mixed cryoglobulinemia (EMC) patients may have lung interstitial involvement. However, lung function does not significantly decline over a 15-month follow-up period in these patients.
Area of Science:
- Pulmonology
- Rheumatology
- Immunology
Background:
- Lung involvement in essential mixed cryoglobulinemia (EMC) is a recently described phenomenon.
- Patients with EMC may exhibit interstitial lung disease, potentially linked to immune complex deposition.
Purpose of the Study:
- To assess the rate of lung function deterioration in patients with essential mixed cryoglobulinemia.
- To evaluate short-term changes in pulmonary function and radiological findings in EMC patients.
Main Methods:
- Nineteen patients with EMC underwent pulmonary function tests, chest X-rays, and serologic investigations.
- A short-term follow-up of approximately 15 months was conducted to monitor changes.
Main Results:
- Baseline evaluation revealed reduced forced expiratory flows, interstitial lung signs on chest X-ray, and decreased diffusing capacity.
- Over 15 months, maximal expiratory flow, total lung capacity, functional residual capacity, and CO transfer coefficient showed slight decreases.
- Hemolytic complement (CH50) and complement fraction (C3) levels also slightly decreased.
Conclusions:
- Patients with essential mixed cryoglobulinemia exhibit pulmonary interstitial involvement, likely due to immune complex deposition.
- Despite interstitial changes, EMC patients do not experience a severe decline in lung function over the short term.
- Regular monitoring of lung function and chest X-rays is recommended for EMC patients.